Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
557
datasets available to search
ShareScore release 0.9.0
Dataset results
557 results for “imatinib”
ESHAP-Imatinib for Refractory/Relapsed Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT02431403. IPD Sharing: Not stated. Countries: 1. Publications: 29.
Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy
ClinicalTrials.gov study NCT00896129. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Trial to Evaluate the Improvement of Chronic Low-grade AEs in Patients With Ph+ CML With Optimal Response to Imatinib When Switched to Nilotinib
ClinicalTrials.gov study NCT02115386. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Docetaxel and Imatinib Mesylate in Treating Patients With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00080665. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Pulmonary Hypertension and Imatinib
ClinicalTrials.gov study NCT01092897. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Pioglityazone and Imatinib for CML Patients
ClinicalTrials.gov study NCT02888964. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Imatinib in KIT-negative Systemic Mastocytosis
ClinicalTrials.gov study NCT01297777. IPD Sharing: NO. Countries: 1. Publications: 7.
Imatinib Mesylate and Capecitabine in Treating Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT00253565. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment
ClinicalTrials.gov study NCT00632255. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Low-dose Nilotinib and Imatinib Combination in Chronic Myeloid Leukemia Patients, With Failure, Suboptimal Response or Treatment Intolerance
ClinicalTrials.gov study NCT01819389. IPD Sharing: Not stated. Countries: 1. Publications: 4.
A Pilot Study of Imatinib Mesylate in Steroid Refractory Chronic Graft Versus Host Disease
ClinicalTrials.gov study NCT00760981. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Imatinib in Dermatofibrosarcoma Protuberans (DFSP)
ClinicalTrials.gov study NCT00122473. IPD Sharing: Not stated. Countries: 1. Publications: 11.
Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate Therapy
ClinicalTrials.gov study NCT00264160. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Surgery for Locally Unresectable Advanced GISTs Without Metastasis After Imatinib Therapy
ClinicalTrials.gov study NCT01865565. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
ClinicalTrials.gov study NCT00816114. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Efficacy and Safety of Imatinib in Chordoma
ClinicalTrials.gov study NCT00150072. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Registration of Children With CML and Treatment With Imatinib
ClinicalTrials.gov study NCT00445822. IPD Sharing: Not stated. Countries: 1. Publications: 13.
Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer
ClinicalTrials.gov study NCT00372476. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Long-term Risk of Second Primary Malignancies for Chronic Myeloid Leukaemia in the French Imatinib-based SPIRIT Trial
ClinicalTrials.gov study NCT06646978. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Exploratory Study of IMATINIB High Dose in Intermediate Risk Chronic Myeloid Leukemia in Chronic Phase
ClinicalTrials.gov study NCT00510926. IPD Sharing: Not stated. Countries: 1. Publications: 7.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.